| ELAV-Like Protein 4 | |
|---|---|
| Protein Name | ELAV-Like Protein 4 (HuD) |
| Gene | ELAVL4 |
| UniProt ID | P26378 |
| PDB ID | 1BA7, 1BXU, 5T15 |
| Molecular Weight | 38 kDa |
| Amino Acids | 326 |
| Subcellular Localization | Nucleus, Cytoplasm |
| Protein Family | ELAV/Hu family |
| Brain Expression | Hippocampus, Cortex, Cerebellum |
| Diseases | ALS, FTD, AD |
ELAVL4 (ELAV-Like Protein 4), also known as HuD, is a neuron-specific RNA-binding protein encoded by the ELAVL4 gene located on chromosome 1p34.2. It belongs to the ELAV (Embryonic Lethal, Abnormal Vision, Drosophila) family of RNA-binding proteins, which in mammals includes ELAVL1 (HuR), ELAVL2 (HuB), ELAVL3 (HuC), and ELAVL4 (HuD). These proteins are characterized by their ability to bind AU-rich elements (AREs) in the 3' untranslated regions (UTRs) of messenger RNAs (mRNAs), thereby regulating mRNA stability, localization, and translation.
ELAVL4 is primarily expressed in neuronal tissues and plays critical roles in neuronal development, differentiation, synaptic plasticity, and maintenance of neuronal identity. In the context of neurodegenerative diseases, ELAVL4 has been implicated in Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), and Alzheimer's Disease (AD). Dysregulation of ELAVL4 function contributes to TDP-43 proteinopathy, a hallmark of ALS/FTD spectrum disorders, and affects synaptic protein expression in AD[1].
ELAVL4 is a 326-amino acid protein that contains three highly conserved RNA recognition motifs (RRMs), each consisting of approximately 90 amino acids with the canonical RNP1 (octamer) and RNP2 (hexamer) sequence motifs. The protein localizes to both the nucleus and cytoplasm of neurons, where it performs distinct functions in each compartment. In the nucleus, ELAVL4 participates in alternative splicing regulation, while in the cytoplasm, it controls mRNA stability and translational efficiency[2].
The ELAVL4 gene (NCBI Gene ID: 19988) is expressed predominantly in the central nervous system, with highest levels in the hippocampus, cerebral cortex, and cerebellum. Expression begins during embryonic development and persists throughout adulthood, reflecting its essential role in neuronal maintenance. Mutations in ELAVL4 have been associated with increased risk of ALS and FTD, highlighting its importance in motor neuron and frontal/temporal lobe biology[3].
ELAVL4 contains three highly conserved RRMs arranged in tandem:
RRM1 (aa 17-96)
RRM2 (aa 102-184)
RRM3 (aa 200-280)
Crystal structures of ELAVL4 RRM domains bound to RNA have revealed the molecular basis of RNA recognition. The RRM fold consists of a four-stranded β-sheet flanked by two α-helices, with the RNP motifs located on the β3 and β1 strands, respectively, creating an RNA-binding surface[4].
ELAVL4 recognizes and binds to AU-rich elements (AREs) in the 3' UTRs of target mRNAs through its RRM domains. The protein can either stabilize or destabilize bound mRNAs, depending on the context and associated proteins:
mRNA Stabilization:
mRNA Translational Control:
Key neuronal mRNAs regulated by ELAVL4 include:
| mRNA Target | Function | Disease Relevance |
|---|---|---|
| MAPT (Tau) | Microtubule stability | AD, FTD |
| APP | Amyloid precursor protein | AD |
| BDNF | Neurotrophin | Neuronal survival |
| GRIA1/2 | AMPA receptor subunits | Synaptic plasticity |
| SNCA | α-Synuclein | PD |
| TARDBP | TDP-43 | ALS, FTD |
In the nucleus, ELAVL4 influences alternative splicing of neuronal pre-mRNAs. It interacts with components of the spliceosome and modulates the inclusion or exclusion of specific exons. This function is particularly important for generating neuronal isoform diversity[5].
ELAVL4 is expressed throughout the brain with highest levels in:
Expression data from the Allen Human Brain Atlas confirms these patterns, with ELAVL4 mRNA detectable in most neuronal populations but absent from glial cells[6].
ELAVL4 is increasingly recognized as an important player in ALS pathogenesis:
Mechanisms:
Genetic Evidence:
ELAVL4 dysfunction contributes to FTD through overlapping mechanisms with ALS:
Pathology:
Clinical Overlap:
ELAVL4 plays complex roles in AD pathogenesis:
Protective Functions:
Disease-Promoting Effects:
Emerging evidence links ELAVL4 to PD:
ELAVL4 interacts with numerous proteins involved in RNA metabolism and neurodegeneration:
The study of Elavl4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page auto-generated and expanded from NeuroWiki protein database. Last updated: 2026-03-06.